Ceres Nanosciences
Manassas, US · Delaware corporation
Ceres Nanosciences develops Nanotrap particle technology, a magnetic hydrogel used to capture, concentrate, and preserve low-abundance analytes such as pathogens, proteins, and cell-free biomarkers from complex biological and environmental samples. Its products support sample preparation for molecular, proteomic, and culture-based workflows including PCR, sequencing, mass spectrometry, liquid biopsy, and wastewater surveillance.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$8M disclosed across 2 rounds · 2017–2022
▶$5MraisedSep 2022 · 1 investors · BiotechnologyRule 506(c)
- Ross DunlapExecutive Officer, Director
- Ian WrightDirector
- Scott GazelleDirector
- Tom MillerDirector
- Emanuel PetricoinDirector
- Amount sold
- $5M
- Minimum investment
- $5M
- First sale
- Sep 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$3MraisedFeb 2017 · 1 investors · BiotechnologyRule 506(c)
- Tom MillerDirector
- Scott GazelleDirector
- Ross DunlapExecutive Officer, Director
- Thomas DunlapExecutive Officer
- Emanuel Petricoin IIIDirector
- Offering amount
- $9M
- Amount sold
- $3M
- Minimum investment
- $100K
- First sale
- Jan 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlap
Companies competing with Ceres Nanosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 7 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2020 | $387.3K |
| Centers for Disease Control and Prevention (CDC)Centers for Disease Control and Prevention | Phase I | 2020 | $243.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $224.8K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase II | 2016 | $1.7M |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase ISTTR | 2013 | $99.8K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase II | 2012 | $999.7K |
| Defense Advanced Research Projects Agency (DARPA)Defense Advanced Research Projects Agency | Phase I | 2012 | $149.8K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Ceres Nanosciences do?
- Ceres Nanosciences develops Nanotrap particle technology, a magnetic hydrogel used to capture, concentrate, and preserve low-abundance analytes such as pathogens, proteins, and cell-free biomarkers from complex biological and environmental samples. Its products support sample preparation for molecular, proteomic, and culture-based workflows including PCR, sequencing, mass spectrometry, liquid biopsy, and wastewater surveillance.
- Who founded Ceres Nanosciences?
- Ceres Nanosciences was founded by Ross Dunlap, Emanuel Petricoin III.
- How much funding has Ceres Nanosciences raised?
- Ceres Nanosciences has disclosed $8M raised across 2 rounds.
- Where is Ceres Nanosciences headquartered?
- Ceres Nanosciences is headquartered in Manassas, US.